Abstract:: The 2005 ATS/IDSA guidelines for the management of hospital-acquired pneumonia (HAP) classified patients according to Background time-onset and risk factors for potentially-resistant microorganisms (PRM) in order to select the empiric antimicrobial treatment. We assessed the microbial prediction and validated the adequacy of these guidelines for antibiotic strategy.: We prospectively evaluated 276 cases of ICU-acquired pneumonia. We classified patients into Group 1 (early-onset without risk Methods factors f… Show more
“…To the best of our knowledge, only one study [30 ] has validated microbial prediction and adequacy of antimicrobial treatment in the 2005 ATS/IDSA guidelines. A prospective, observational study was recently performed in 276 patients with clinical suspicion of ICU-acquired pneumonia.…”
Section: Microbial Prediction Efficacy and Validation Of The 2005 Amementioning
Guidelines implementation can improve outcomes. To achieve this goal, guidelines should be adapted to local microbiology, accurately predict VAP pathogens and help physicians to administer the most appropriate empirical antimicrobial therapy.
“…To the best of our knowledge, only one study [30 ] has validated microbial prediction and adequacy of antimicrobial treatment in the 2005 ATS/IDSA guidelines. A prospective, observational study was recently performed in 276 patients with clinical suspicion of ICU-acquired pneumonia.…”
Section: Microbial Prediction Efficacy and Validation Of The 2005 Amementioning
Guidelines implementation can improve outcomes. To achieve this goal, guidelines should be adapted to local microbiology, accurately predict VAP pathogens and help physicians to administer the most appropriate empirical antimicrobial therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.